| Patient | Mary McLeod Bethune |
|---|---|
| Date of birth | 1875-07-10 |
| Identifiers | MRN HR-ML043-SYN-TD; SSN (made up) 000-43-2195 |
| Document date | 1948-06-15 |
| Author | Viola Harrington-Mbeki, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Worsening wheeze and breathlessness for two days with a cold. [S]
Mrs. Bethune called the clinic this morning from the yellow zone of her action plan and was seen the same day. Five days ago she developed a cold with a runny nose and sore throat after a crowded church gathering. For two days her wheeze and chest tightness have worsened; she woke three times last night and has needed eight extra inhalations of budesonide-formoterol in each of the last two days, as her plan allows. Her morning peak flow has fallen from about 300 to 210 L/min. She can speak in full sentences and has no chest pain. She has no fever, green sputum or leg swelling, and has had no ankle swelling or orthopnea that would suggest heart failure. She takes her maintenance inhalations with the spacer, amlodipine and atorvastatin as prescribed. She has never been admitted to hospital for asthma or needed a breathing tube. [S]
| Element | Detail |
|---|---|
| Onset | Cold five days ago; asthma worse for two days |
| Severity | Woke three times last night; eight reliever inhalations a day; morning peak flow 210 L/min |
| Context | Low-dose budesonide-formoterol maintenance and reliever; yellow zone of her action plan |
| Associated signs and symptoms | Runny nose and sore throat; no fever, chest pain, purulent sputum or leg swelling |
| Risk history | No previous admission, intensive care or intubation for asthma; no oral corticosteroid in the past year |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired; temperature 37.4 °C; no rigors |
| Respiratory | Positive | Wheeze, chest tightness and night waking; dry cough; no hemoptysis |
| Ears, nose, mouth, and throat | Positive | Runny nose and sore throat |
| Cardiovascular | Negative | No chest pain, orthopnea or ankle swelling |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Albuterol 90 mcg/actuation inhaler, two puffs as needed, from an urgent care visit four months ago (used alone, without an inhaled steroid) | Two puffs every 4 hours as needed; she uses it most days | Respiratory tract route | 1947-11-03 to 1948-03-23 | completed | S |
| Prednisone 20 mg oral tablet, two tablets (40 mg) by mouth each morning for five days | 40 mg each morning for five days | Oral route | 1948-06-15 to 1948-06-19 | completed | S |
| Budesonide-formoterol 160/4.5 mcg inhaler as maintenance and reliever (GINA track 1, step 3): one inhalation twice daily and one inhalation as needed for symptoms, no more than 12 inhalations a day | One inhalation twice daily plus one as needed | Respiratory tract route | 1948-03-23 to 1948-06-15 | completed | S |
| Budesonide-formoterol 160/4.5 mcg inhaler with a spacer: two inhalations twice daily and one as needed (stepped up during the exacerbation), no more than 12 inhalations a day | Two inhalations twice daily plus one as needed | Respiratory tract route | 1948-06-15 to 1948-07-27 | completed | S |
| Fluticasone propionate 50 mcg/actuation nasal spray, two sprays in each nostril once daily, aimed away from the septum | Two sprays each nostril daily | Nasal route | 1948-03-23 | active | S |
| Sodium chloride 0.65% nasal spray, two sprays in each nostril up to four times daily before the steroid spray | Two sprays each nostril up to four times daily | Nasal route | 1948-03-23 | active | S |
| Amlodipine 5 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1948-03-23 | active | S |
| Atorvastatin 20 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1948-03-23 | active | S |
| Omeprazole 20 mg delayed-release capsule, one capsule daily 30 minutes before breakfast for eight weeks | One capsule daily before breakfast | Oral route | 1948-03-23 to 1948-05-18 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1948-06-15 | Body height | 163 | cm | S |
| 1948-06-15 | Body weight | 87.2 | kg | S |
| 1948-06-15 | Body mass index (BMI) [Ratio] | 32.8 | kg/m2 | S |
| 1948-06-15 | Systolic blood pressure | 138 | mm[Hg] | S |
| 1948-06-15 | Diastolic blood pressure | 82 | mm[Hg] | S |
| 1948-06-15 | Heart rate | 98 | /min | S |
| 1948-06-15 | Respiratory rate | 22 | /min | S |
| 1948-06-15 | Body temperature | 37.4 | Cel | S |
| 1948-06-15 | Oxygen saturation in Arterial blood by Pulse oximetry | 94 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1948-06-15 | Maximum expiratory gas flow Respiratory system airway by Peak flow meter | 205 | L/min | 80 percent of her personal best of 340 L/min | Low | S |
Vital signs recorded on 1948-06-15; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Alert, sitting upright, speaking in full sentences; not using accessory muscles |
| Vital signs | Pulse 98, respiratory rate 22, oxygen saturation 94 percent on room air, temperature 37.4 °C; peak flow 205 L/min (60 percent of her best) |
| Head, eyes, ears, nose, and throat | Red throat; clear nasal discharge |
| Respiratory | Widespread expiratory wheeze with good air entry; no crackles |
| Cardiovascular | Regular rhythm; jugular venous pressure not raised; no edema |
| Reassessment after one hour | After albuterol 8 puffs by spacer three times over an hour: peak flow 275 L/min (81 percent), oxygen saturation 96 percent, pulse 92, wheeze much reduced |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Wheeze, cough and breathlessness for four months: waking with cough and tight chest two or three nights a week, breathless on one flight of stairs, relieved by albuterol, worse with colds, dust and strong scents; known asthma for many years but never confirmed by lung function testing and never treated with an inhaled steroid. Asthma, COPD and heart failure to be distinguished: spirometry with bronchodilator response, FeNO and an echocardiogram booked | resolved | confirmed | R06.2 | S — Synthetic presenting problem anchored to her documented chronic asthma. Superseded by the diagnosis at the second visit. |
| Blocked nose, thick postnasal drip and a reduced sense of smell for years, worse in the last year; no nosebleeds; never seen by an ear, nose and throat specialist | resolved | confirmed | R09.81 | S — Synthetic upper-airway symptoms; superseded by the diagnosis of chronic rhinosinusitis after nasal endoscopy. |
| Gastro-esophageal reflux: heartburn and an acid taste two or three evenings a week, worse after late meals and lying down; no trouble swallowing, vomiting, black stools or weight loss | active | confirmed | K21.9 | S — Synthetic comorbidity of asthma; not a claim about her real health. |
| Obesity, class 1 (BMI 33.1); she wants to walk more and to keep up with her work, and agreed to talk about it | active | confirmed | E66.811 | S — Synthetic comorbidity recorded in her words and with her agreement; not a claim about her real weight. |
| Moderate asthma exacerbation triggered by a cold: two days of worsening wheeze and night waking despite eight reliever inhalations a day, peak flow 205 L/min (60 percent of her best), oxygen saturation 94 percent; improved to 275 L/min in clinic; treated without admission; resolved | active | confirmed | J45.41 | S — Synthetic exacerbation; not a claim about a real attack. |
| Asthma, confirmed: variable airflow obstruction (FEV1 64 percent predicted, rising 270 mL or 21 percent after bronchodilator, with a normal post-bronchodilator FEV1/FVC of 0.72 and normal DLCO); type 2 inflammation (FeNO 46 ppb, blood eosinophils 0.42 x10^3/uL, total IgE 210, house dust mite sensitization); not COPD and not heart failure. Uncontrolled at diagnosis on albuterol alone | active | confirmed | J45.40 | S — Synthetic modern confirmation linked to her documented chronic asthma. |
| Hypertensive heart disease without heart failure: clinic blood pressure 152/88 and 146/86, home average 144/84; mild concentric left ventricular hypertrophy with grade 1 diastolic dysfunction and a normal ejection fraction (62 percent); BNP 48 pg/mL | active | confirmed | I11.9 | S — Synthetic finding of the modern work-up; not a claim about her real heart. |
| Hyperlipidemia: LDL cholesterol 144 mg/dL; 10-year ASCVD risk above 20 percent with hypertension | active | confirmed | E78.5 | S — Synthetic cardiovascular risk factor. |
| Chronic rhinosinusitis without nasal polyps: years of congestion, postnasal drip and reduced smell, with mucosal swelling and mucus in both middle meatuses and no polyps on nasal endoscopy | active | confirmed | J32.9 | S — Synthetic upper-airway comorbidity of asthma; not a claim about her real health. |
Guideline basis: Global Strategy for Asthma Management and Prevention, 2025 update (2025); 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group (2020)
Follow-up: Nurse telephone calls in two and seven days. Clinic review within a week. Emergency care for any red-zone sign. Next scheduled visit 1948-07-27: review six weeks after an exacerbation: control, repeat spirometry and FeNO, biologic assessment, blood pressure and the post-exacerbation plan. [S]